Weißbuch Radioligandentherapie in Deutschland
Nuclear medicine has traditionally been strongly diagnostically oriented, but in recent decades has increasingly developed therapeutically as well. A key example of this development is radioligand therapy, which combines diagnostic and therapeutic approaches: Radioactively labeled ligands are initia...
Uloženo v:
| Médium: | Online |
|---|---|
| Jazyk: | němčina |
| Vydáno: |
MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
2025
|
| Témata: | |
| On-line přístup: | https://library.oapen.org/handle/20.500.12657/103417 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| _version_ | 1869529900858212352 |
|---|---|
| collection | Directory of Open Access Books |
| description | Nuclear medicine has traditionally been strongly diagnostically oriented, but in recent decades has increasingly developed therapeutically as well. A key example of this development is radioligand therapy, which combines diagnostic and therapeutic approaches: Radioactively labeled ligands are initially used for imaging and subsequently for targeted treatment. This method is currently used primarily for neuroendocrine tumors and prostate cancer.
The White Paper offers a comprehensive analysis of the current state of nuclear medicine diagnostics and therapy, identifies existing gaps in care, and develops concrete recommendations for the further development of care structures.
It is based on the assessments of expert panels from clinical practice, health insurance providers, and patient advocacy groups. Key challenges are systematically examined, including outpatient care, reimbursement structures, and the implementation of innovative therapeutic approaches.
The work is aimed at decision-makers in the healthcare system – including medical professionals, payers, political actors, professional societies, regulatory institutions, and patient organizations – and is intended to serve as a sound basis for the further development of nuclear medicine care. |
| format | Online |
| id | doab-20.500.12854ir-161229 |
| institution | Directory of Open Access Books |
| language | ger |
| publishDate | 2025 |
| publishDateRange | 2025 |
| publishDateSort | 2025 |
| publisher | MWV Medizinisch Wissenschaftliche Verlagsgesellschaft |
| publisherStr | MWV Medizinisch Wissenschaftliche Verlagsgesellschaft |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1612292025-06-12T05:02:55Z Weißbuch Radioligandentherapie in Deutschland Berkemeier, Fabian Krieger, Julia Sussmann, Stephanie Access to care; Enlightenment; Intersectoral care; Patient Communication; Prostate carcinoma; Radioligandtherapy; Radionuclide therapy; Remuneration; Nuclear medicine thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBP Health systems and services::MBPA Primary care medicine, primary health care Nuclear medicine has traditionally been strongly diagnostically oriented, but in recent decades has increasingly developed therapeutically as well. A key example of this development is radioligand therapy, which combines diagnostic and therapeutic approaches: Radioactively labeled ligands are initially used for imaging and subsequently for targeted treatment. This method is currently used primarily for neuroendocrine tumors and prostate cancer. The White Paper offers a comprehensive analysis of the current state of nuclear medicine diagnostics and therapy, identifies existing gaps in care, and develops concrete recommendations for the further development of care structures. It is based on the assessments of expert panels from clinical practice, health insurance providers, and patient advocacy groups. Key challenges are systematically examined, including outpatient care, reimbursement structures, and the implementation of innovative therapeutic approaches. The work is aimed at decision-makers in the healthcare system – including medical professionals, payers, political actors, professional societies, regulatory institutions, and patient organizations – and is intended to serve as a sound basis for the further development of nuclear medicine care. 2025-06-12T05:02:54Z 2025-06-12T05:02:54Z 2025-06-11T08:23:01Z 2025 book https://library.oapen.org/handle/20.500.12657/103417 https://directory.doabooks.org/handle/20.500.12854/161229 ger open access image/jpeg Attribution-NonCommercial-NoDerivatives 4.0 International https://library.oapen.org/bitstream/20.500.12657/103417/1/wei%c3%9fbuch-radioligandentherapie-in-deutschland.pdf MWV Medizinisch Wissenschaftliche Verlagsgesellschaft 10.32745/9783954669851 10.32745/9783954669851 c40cfce7-9c58-4afe-a0f0-974d0995578e 101 open access |
| spellingShingle | Access to care; Enlightenment; Intersectoral care; Patient Communication; Prostate carcinoma; Radioligandtherapy; Radionuclide therapy; Remuneration; Nuclear medicine thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBP Health systems and services::MBPA Primary care medicine, primary health care Weißbuch Radioligandentherapie in Deutschland |
| title | Weißbuch Radioligandentherapie in Deutschland |
| title_full | Weißbuch Radioligandentherapie in Deutschland |
| title_fullStr | Weißbuch Radioligandentherapie in Deutschland |
| title_full_unstemmed | Weißbuch Radioligandentherapie in Deutschland |
| title_short | Weißbuch Radioligandentherapie in Deutschland |
| title_sort | weissbuch radioligandentherapie in deutschland |
| topic | Access to care; Enlightenment; Intersectoral care; Patient Communication; Prostate carcinoma; Radioligandtherapy; Radionuclide therapy; Remuneration; Nuclear medicine thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBP Health systems and services::MBPA Primary care medicine, primary health care |
| topic_facet | Access to care; Enlightenment; Intersectoral care; Patient Communication; Prostate carcinoma; Radioligandtherapy; Radionuclide therapy; Remuneration; Nuclear medicine thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBP Health systems and services::MBPA Primary care medicine, primary health care |
| url | https://library.oapen.org/handle/20.500.12657/103417 |